exwannabe,
Big pharma doesn’t like playing come from behind, especially this far behind and they don’t want a cure. You know this and have seen the discussion by their talking heads about why a cure is bad for business and the economy. These are the guys that help shape the rules that help keep the small biotechs under wraps with their financial influence which has at times motivated the officials of “the process” (game) and media (announcers) to make sure the rules, or the interpretation of them, and the dialogue favor big pharma. Well NWBO started playing in a different league where that influence is not as great and the media is much more willing to provide coverage of a state of the art facility preparing to deliver a personalized biologic treatment PLATFORM on a grand, commercialized, perhaps standard of career scale. Big pharma has nothing like this in their arsenal. Best wishes.
Market Data 
Markets 
AI
